Study of microbiome changes in patients with ulcerative colitis in the Central European part of RussiaOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the microbiological composition of the intestines of people with ulcerative colitis (UC) compared with healthy individuals. UC is an inflammatory disease affecting the colon and rectum, and the authors note that the role of intestinal microbiota in its pathogenesis has been incompletely characterized. The researchers used sequencing on the IonTorrent PGM system followed by data analysis to profile bacterial genera and species. They specifically framed the work as addressing a gap in comprehensive data on the microbial composition of UC patients in Russia.
Who was studied?
The study compared patients with ulcerative colitis to a control group of healthy individuals, with intestinal samples analyzed from both groups. The abstract does not give an exact number of participants, so no specific cohort size can be stated. The population is described as being from the Central European part of Russia, addressing what the authors describe as a lack of prior microbiological data on UC patients in that country.
What were the most important findings?
Sequencing revealed significant changes in bacterial genera and species in UC patients compared with controls. Several genera were significantly increased in UC patients, including Haemophilus, Olsenella, Prevotella, Cedecea, Peptostreptococcus, Faecalibacterium, Lachnospira, Negativibacillus, and Butyrivibrio. Species-level increases included Bacteroides coprocola, Phascolarctobacterium succinatutens, Dialister succinatiphilus, Sutterella wadsworthensis, and Faecalibacterium prausnitzii. Notably, F. prausnitzii, an organism often associated with butyrate production and anti-inflammatory commensal activity, was found elevated rather than depleted in these UC patients.
What are the greatest implications of this study?
The findings suggest that ulcerative colitis in this Russian cohort is associated with distinct shifts in gut microbial genera and species relative to healthy controls, expanding the geographic evidence base for microbiota-UC associations. The unexpected increase in Faecalibacterium and F. prausnitzii, rather than the depletion sometimes reported elsewhere, highlights that microbial signatures in UC may vary by population and underscores the need for region-specific microbiome characterization. These results support continued investigation into the intestinal microbiota as a factor in UC pathogenesis rather than establishing a definitive causal mechanism.